Close
Novotech
Jabsco PureFlo 21 Single Use

News

Frontage Expands Early Drug Discovery Services through the Acquisition of Heyan Biotech

Frontage Shanghai announced the acquisition of 70% equity interest in Wuhan Heyan Biomedical Technology Co., Ltd. Heyan Biotech, located in Wuhan Optics Valley, national biotech industry base, provides for target based in vitro pharmacodynamic screening and early pharmacological pharmacodynamic...

AGC Bio Expands pDNA and mRNA Manufacturing Capacity at Heidelberg Facility

AGC Biologics announced expansion plans for the company’s Heidelberg facility to increase manufacturing capacities for plasmid-DNA (pDNA) and messenger RNA (mRNA) projects. With this expansion, AGC Biologics is boosting its current 100L and 1,000L manufacturing capacities for a variety of...

Samsung Biologics Joins Frontier 1.5D Project as part of 2050 Carbon Neutral Initiative

Samsung Biologics, the world’s leading contract development and manufacturing organization, announced the signing of an MOU to participate in the Frontier 1.5D initiative to develop a climate risk management model as part of 2050 Carbon Neutral Strategy in response...

Anaqua Delivers Enhanced IP Management to Bausch Health

Anaqua , the leading innovation and intellectual property management technology provider, announced that Bausch Health Companies Inc. has selected Anaqua’s AQX platform to deliver enhanced IP management across the health care products company’s global operations. Bausch Health will be using...

Peli BioThermal Showcase Life-Saving Products at DSEI

Peli BioThermal, the global name in temperature controlled packaging solutions, will showcase its latest version of Golden Hour™One products for the first time at DSEI 2021, the world’s largest gathering of the defence and security community. The Peli BioThermal team...

Recro and BioCorRx expand partnership for OUD treatment

Recro Pharma, Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges in small molecule therapeutic development, and BioCorRx, Inc., a developer and provider of advanced solutions in the treatment of substance use...

GeneQuine Selects Exothera to Support the Next Stage of Its Osteoarthritis Gene Therapy Development

GeneQuine Biotherapeutics GmbH, a biotech company focused on the development of gene therapy for musculoskeletal disorders, announced that it has contracted Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO), to conduct a feasibility study for the development...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »